Daily Stock Market Report (Fri 18 July 2025) - CRPR, AGFX, BRBY, GSK, SNR, AT.
Good morning!
To get started with we have a backlog section from Mark on James Cropper (LON:CRPR), which issued annual results yesterday.
It's a fairly quiet day for news today, so I'll aim to take a look at one or two backlog items from yesterday - including Ashtead Technology Holdings (LON:AT.).
Spreadsheet accompanying this report: link.
The agenda is now complete.
Report complete at 12.30: that's all we have time for today, enjoy your weekend.
Companies Reporting
Name (Mkt Cap)RNSSummaryOur view (Author)BHP (LON:BHP) (£98bn)Quarterly Activities ReportFY copper +8% to gt;2.0Mt, “record” iron ore prod. Jansen Stage 1 now exp $7-7.4bn vs $5.7bn prev.GSK (LON:GSK) (£58bn)Blenrep US ODAC outcomeSP -5%The FDA’s Oncologic Drugs Advisory Committee (ODAC) has voted against proposed dosage of Blenrep for use to treat myeloma (a type of blood cancer). A final FDA decision on approval is due on 23 July 2025.AMBER (Roland) [no section below]I don’t follow pharma stocks closely as I lack the knowledge to understand their products in any detail. But today’s announcement does look disappointing. An expert...